Jun 30, 2021 | Press Releases
INVO Bioscience and established reproductive specialist Dr. Sue Ellen Carpenter, MD of Bloom Fertility today announce their partnership to make INVOcell, an innovative technology that allows early embryo development to take place within the woman’s body, more...
Jun 15, 2021 | Press Releases
SARASOTA, Fla., June 15, 2021 – INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world’s only in vivo Intravaginal Culture System (IVC), INVOcell®, an effective and affordable treatment for patients...
May 17, 2021 | Press Releases
Company to Host Conference Call Today at 4:30pm ET (Details Below)SARASOTA, Fla., May 17, 2021 — INVO Bioscience, Inc. (Nasdaq: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of...
May 11, 2021 | Press Releases
Financial results to be released after market close; Conference call to be conducted at 4:30 pm ETSARASOTA, Fla., May 11, 2021 – INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world’s only in vivo...
May 10, 2021 | Press Releases
Aggressive go-to-market sales, partnerships, and marketing strategy to bring INVOcell, fertility care that is accessible, inclusive, and affordable to the more than 90% of couples in need of fertility treatment that currently go without care.SARASOTA, Fla., May 10,...
Apr 26, 2021 | Press Releases
Current Senior Advisor at McKinsey & Co. with strong expertise in global marketing and brand buildingSARASOTA, Fla., April 26, 2021 – INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world’s only in...
